Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications

International Journal of Obesity

Volumn 24, Issue , 2000, Pages S8-S17

  Bray, G A ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Glucocorticoids; Hypothalamus; Neuropeptide Y; Sympathetic nerves; agonists

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ALPHA INTERMEDIN; BETA ENDORPHIN; CAFFEINE; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; DEXFENFLURAMINE; ENTEROSTATIN; EPHEDRINE; GALANIN; GLUCOCORTICOID; LEPTIN; MELANIN CONCENTRATING HORMONE; MELANOCORTIN RECEPTOR; MONOAMINE; NEUROPEPTIDE; NEUROPEPTIDE Y; NICOTINE; NORADRENALIN; OREXIN; PROSTAGLANDIN; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2C RECEPTOR; SIBUTRAMINE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; BODY FAT; CONFERENCE PAPER; ENERGY EXPENDITURE; FOOD INTAKE; HUMAN; LIPID STORAGE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SYMPATHETIC TONE; THERMOGENESIS; TRANSGENIC MOUSE; WEIGHT REDUCTION;

ANIMALS; EATING; GLUCOCORTICOIDS; HUMANS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; SYMPATHETIC NERVOUS SYSTEM;

ANIMALIA; MUS MUSCULUS;

EID: 0033943102     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801269     Document Type: Article

References (101)

1. Bray GA. Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis. JNutr 1991; 121: 1146-1162.
2. Bray GA. Reciprocal relation between the sympathetic nervous system and food intake. Brain Res Bull 1991; 27: 517-520.
3. Bray GA, York DA. The MONA LISA hypothesis in the time of leptin. Ree Prog Hormone Res 1998: 53: 95-117.
4. Bouchard C, Bray GA. Regulation of body weight: biological and behavioral mechanisms. Dahlem Workshop report LS 57. J Wiley: Chichester, 1996, pp 1-323.
5. Young JB, Landsberg L. Suppression of sympathetic neuron system during fasting. Science 1977; 196: 1473-1475.
6. Rappoport EB, Young JB, Landsberg L. Effects of 2-deoxy-D-glucose on the cardiac sympathetic nerves and the adrenal medulla in the rat: further evidence for a dissociation of sympathetic nervous system and adrenal medullary responses. Endocrinology 1982; 110: 650-656.
7. Inoue S, Campfield LA, Bray GA. Comparison of metabolic alterations in hypothalamic and high fat diet-induced obesity. Am J Physiol 1977; 233(3): R162-R168.
8. Nishizawa Y, Bray GA. Ventromedial hypothalamic lesions and the mobilization of fatty acids. J Clin Invest 1978; 61 (3): 714-721.
9. Bray GA, Nishizawa Y. Ventromedial hypothalamus modulates fat mobilization during fasting. Nature 1978; 274 (5674): 900-902.
10. Vander Tuig JG, Knehans AW, Romsos DR. Reduced sympathetic nervous activity in rats with ventromedial hypothalamic lesions. Life Sci 1982; 30: 913-920.
11. Niijima A, Rohner-Jeanrenaud F, Jeanrenaud B. Role of ventromedial hypothalamus on sympathetic efferents of brown adipose tissue. Am J Physiol 1984; 247: R650-R654.
12. Sakaguchi T, Arase K, Bray GA. Sympathetic activity and food intake of rats with ventromedial hypothalamic lesions. Int JObes 1988; 12: 43-49.
13. Powley TL, Opsahl CA. Ventromedial hypothalamic obesity abolished by subdiaphragmatic vagotomy. Am J Physiol 1974; 226: 25-33.
14. Inoue S, Bray GA. The effect by subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity. Endocrinology 1977; 100: 108-114.
15. Bray GA, York DA, Fisler JS. Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system. Vitam Horm 1989; 45: 1-125.
16. Tokunaga K, Fukushima M, Kemnitz JW, Bray GA. Effect of vagotomy on serum insulin in rats with paraventricular or ventromedial hypothalamic lesions. Endocrinology 1986; 119(4): 1708-1711.
17. Jeanrenaud B. Neuroendocrinology and evolutionary aspects of experimental obesity. In: Oomura Y, Tazui S, Inoue S, Shimazu T (eds). Progress in obesity research. John Libbey: London, 1990, pp 409-421.
18. Parameswaran SV, Steffens AB, Hervey GR, de Ruiter L. Involvement of a humoral factor in regulation of body weight in parabiotic rats. Am J Physiol 1977; 232: R150-R157.
19. Anand BK, Brobeck JR. Hypothalamic control of food intake in rats and cats. Yale J Biol Med 1951; 24: 123-146.
20. Yoshida T, Kemnitz JW, Bray GA. Lateral hypothalamic lesions and norepinephrine turnover in rats. J Clin Invest 1983; 72: 919-927.
21. Arase K, Sakaguchi T, Bray GA. Lateral hypothalamic lesions and activity of the sympathetic nervous system. Life Sci 1987; 41: 657-662.
22. Powley TL, Keesey RE. Relationship of body weight to the lateral hypothalamic feeding syndrome. J Comp Physiol Psychol 1970; 70: 25-36.
23. Levitsky DA, Strupp BJ, Lupoli J. Tolerance to anorectic drugs: pharmacological or artifactual. Pharmac Biochem Behav 1981; 14: 661-667.
24. Arase K, Sakaguchi T, Bray GA. Effect of fenfluramine on sympathetic firing rate. Pharmac Biochem Behav 1988; 29: 675-680.
25. Sakurai T, Amemiya A, Ishii M et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 20: 573-585.
26. Sakaguchi T, Takahashi M, Bray GA. Diurnal changes in sympathetic activity: relation to food intake and to insulin injected into the ventromedial or suprachiasmatic nucleus. J Clin Invest 1988; 32: 282-286.
27. Stanley G, Anderson K, Grayson M, Leibowitz S. Repeated hypothalamic stimulation with neuropeptide Y increases daily carbohydrate and fat intake and body weight gain in female rats. Physiol Behav 1989; 46: 173-177.
28. Egawa M, Yoshimatsu H, Bray GA. Effect of corticotropin releasing hormone and neuropeptide Y on electrophysiolo-gical activity of sympathetic nerves to interscapular brown adipose tissue. Neuroscience 1990; 34(3): 771-775.
29. Egawa M, Yoshimatsu H, Bray GA. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am J Physiol 1991; 260: R328-R334.
30. Billington CJ, Briggs JE, Levine AS. Effects of intracereb-roventricular injection of neuropeptide Y on energy metabolism. Am J Physiol 1990; 260: R321-R327.
31. Kotz CM, Grace MK, Briggs J, Levine AS, Billington CJ. Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action. J Clin Invest 1995; 96 (1): 163-170.
32. Egawa M, Yoshimatsu H, Bray GA. Effect of β-endorphin on sympathetic nerve activity to interscapular brown adipose tissue. Am J Physiol 1993; 264: R109-R115.
33. Nagase H, Bray GA, York DA. Effect of galanin and enterostatin on sympathetic nerve activity to interscapular brown adipose tissue. Brain Res 1996; 709: 44-50.
34. Smith FJ, Campfield LA, Oschera JA, Bailon P, Burn P. Feeding inhibition by neuropeptide Y. Nature 1996; 382: 307.
35. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature Sci 1996; 380: 677.
36. Arase K, Shargill N, Bray GA. Effects of corticotropin releasing factor on genetically obese (fatty) rats. Physiol Behav 1989; 45: 1-6.
37. Yoshimatsu H, Egawa M, Bray GA. Effects of cholecysto-kinin on sympathetic activity to interscapular brown adipose tissue. Brain Res 1992; 597: 298-303.
38. Barton C, York DA, Bray GA. Bombesin-induced hypothermia in rats tested at normal ambient temperatures: Contribution of the sympathetic nervous system. Brain Res Bull 1995; 709: 44-50.
39. Connoley JP, Heal DJ, Stock MJ. The thermogenic effects of sibutramine, 7th ICO Satellite Symposium, 18-20, August 1994, p 52 (abstract).
40. McNair E, Bryson R. Effects of nicotine on weight change and food consumption. Pharmac Biochem Behav 1983; 18: 341-344.
41. Lupien JR, Bray GA. Nicotine increases thermogenesis in brown adipose tissue in rats. Pharmac Biochem Behav 1988; 29(1): 33-37.
42. Shimazu T, Noma M, Saito M. Chronic infusion of norepinephrine into the ventromedial hypothalamus induces obesity in rats. Brain Res 1986; 369: 215-223.
43. Smith BK, York DA, Bray GA. Repeated central injections of galanin do not induce sustained hyperphagia or obesity. Peptides 1994; 15: 1267-1272.
44. Davis HR Jr, Mullins DE, Pines JM et al. Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats. Obes Res 1998; 6(2): 147-156.
45. Lin L, Chen J, York DA. Chronic icv enterostatin preferentially reduced fat intake and lowered body weight. Peptides 1997; 18: 657-661.
46. Rossi M, Choi SJ, Oshea D, Miyoshi T, Ghatei MA, Bloom SR. Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body-weight. Endocrinology 1997; 138: 351-355.
47. Holt SJ, York DA. The effects of adrenalectomy corticotropin-releasing hormone and vasopressin on the sympathetic firing rate of nerves to interscapular brown adipose tissue in the Zucker rat. Physiol Behav 1989; 45: 1123-1129.
48. Rohner-Jeanrenaud F, Walker CD, Greco-Perotto R, Jeanrenaud B. Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats. Endocrinology 1989; 124: 733-739.
49. Arase K, Shargill NS, Bray GA. Effect of corticotropin releasing factor on genetically obese (fatty) rats. Physiol Behav 1989; 45: 565-570.
50. Arase K, Shargill N, Bray GA. Effects of intraventricular infusion of corticotropin-releasing factor on VMH-lesioned obese rats. Am J Physiol 1989; 256: R751-R756.
51. Woods SC, Lotter EC, McKay LD, Porte D. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 1979; 282: 503-505.
52. Brief DJ, Davis JD. Reduction of food intake and body weight by chronic intraventricular insulin infusion. Brain Res Bull 1984; 12: 571-575.
53. Arase K, Fisler JS, Shargill NS, York DA, Bray GA. Intracerebroventricular infusions of 3-hydroxybutyrate and insulin in a rat model of dietary obesity. Am J Physiol 1988; 255: R974-R981.
54. Schwartz M, Figlewicz D, Baskin D, Woods S, Porte D. Insulin in the brain: a hormonal regulator of energy balance. EndocrRev 1994; 13: 387-414.
55. Tsujii S, Bray GA. Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists. Brain Res 1992; 587: 226-232.
56. Tsujii S, Bray GA. A β-3 adrenergic agonist (BRL-37344) decreases food intake. Physiol Behav 1998; 63: 723-728.
57. Ookuma K, York DA, Bray GA. Feeding induced after central administration of neuropeptide Y is attenuated with peripheral pretreatment of ß3-adrenergic agonist. Obes Res 1996; 4: 63S.
58. Susulic VS, Frederich RC, Lawitts J et al. Targeted disruption of the ß3-adrenergic receptor gene. J Biol Chem 1995; 270: 29483-29492.
59. Himms-Hagen J. Role of brown adipose tissue thermogenesis in control of thermoregulatory feeding in rats: a new hypothesis that links thermostatic and glucostatic hypotheses for control of food-intake. Proc Soc Exp Biol Med 1995; 208: 159-169.
60. Grujic D, Susulic VS, Harper M et al. β3-adrenergic receptors on white and brown adipocytes mediate ß3-selective agonist-induced effects on energy expenditure, insulin secretion and food intake. J Biol Chem 1997; 272(28): 17686-17693.
61. Yamashita J, Onai T, York DA, Bray GA. Relationship between food intake and metabolic rate in rats treated with ß-adrenoceptor agonists. Intern J Obes 1994; 18: 429-433.
62. Ookuma K, York DA, Bray GA. Feeding induced after central administration of neuropeptide-Y is attenuated with peripheral pretreatment of ß-3 adrenergic agonist. Obes Res 1996; 4: 63S.
63. Lin L, York DA, Bray GA. Comparison of Osborne-Mendel and S5B/PL strains of rat: central effects of galanin, NPY, beta-casomorphin and CRH on intake of high-fat and low-fat diets. Obes Res 1996; 4(2): 117-124.
64. Monda M, Sullo A, Viggiano A, De Luca V. Eating behavior is related to sympathetic activation induced by ICV injection of prostaglandin Ej in the rat. Physiol Behav (in press).
65. Ookuma K, York DA, Bray GA. Changes in sympathetic activity effect feeding responses to neuropeptide Y and corticotropin releasing hormone. Faseb J 1997; 11: A172.
66. Egawa M, Yoshimatsu H, Bray GA. Preoptic area injection of corticotropin-releasing hormone stimulates sympathetic activity. Am J Physiol 1990; 259 (28): R799-R806.
67. Smith FJ, Campfield LA, Oschera JA, Bailon P, Burn P. Feeding inhibition by neuropeptide Y. Nature 1996; 382: 307.
68. Saito M, Bray GA. Adrenalectomy and food restriction in the genetically obese (ob/ob) mouse. Am J Physiol 1984; 246: R20-R25.
69. Yukimura Y, Bray GA, Wolfsen AR. Some effects of adrenalectomy in the fatty rat. Endocrinology 1978; 103: 1924-1928.
70. Shimomura Y, Bray GA, Lee M. Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice. Horm MetabRes 1987; 19: 295-299.
71. Shimizu H, Shargill NS, Bray GA. Adrenalectomy and response to corticosterone and MSH in the genetically obese yellow mouse. Am J Physiol 1989; 256: R494-R500.
72. Shimizu H, Ohshima K, Bray GA, Peterson M, Swerdloff RS. Adrenalectomy and castration in the genetically obese (ob/ob) mouse. Obes Res 1993; 1: 377-383.
73. Vander Tuig JG, Ohshima K, Yoshida T, Romsos DR, Bray GA. Adrenalectomy increases norepinephrine turnover in brown adipose tissue of obese (ob/ob) mice. Life Sci 1984; 34: 1423-1432.
74. Yukimura Y, Bray GA, Wolfson AR. Some effects of adrenalectomy in the fatty rat. Endocrinology 1978; 103 (5): 1924-1928.
75. Holt SJ, York DA. Studies on the sympathetic efferents of brown adipose tissue of lean and obese Zucker rats. Brain Res 1989; 491: 106-112.
76. Shimomura Y, Bray GA, Lee M. Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice. Horm MetabRes 1987; 19: 295-299.
77. Arase K, York DA, Bray GA. Corticosterone inhibition ofthe intracerebroventricular effects of 2-deoxy-D-glucose on brown adipose tissue thermogenesis. Physiol Behav 1987; 41: 489-495.
78. Arase K, York DA, Shargill NS, Bray GA. Interaction of adrenalectomy and fenfluramine treatment on body weight, food intake and brown adipose tissue. Physiol Behav 1989; 45: 557-564.
79. Kakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud B. Glucocorticoids as counter regulatory hormones of leptin: toward and understanding of leptin resistance. Diabetes 1997; 46: 717-719.
80. Astrup A, MacDonald IA. Sympathoadrenal system and metabolism. In: Bray GA, Bouchard C, James WPT (eds). Handbook of obesity. Marcel Dekker: New York, 1998.
81. Young JB, MacDonald IA. Sympathoadrenal activity in human obesity-heterogeneity of findings since 1980. Int J Obes Relat Metab Disord 1992; 16: 959-967.
82. Peterson HR, Rothschild M, Weinberg CR, Fell RD, McLe-ish KR, Pfeifer MA. Body fat and the activity of the autonomic nervous system. N Engl J Med 1988; 318: 1077-1083.
83. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous activity: a potential mechanism predisposing to body weight gain. J Clin Invest 1993; 92: 1730-1735.
84. Scherrer U, Randin D, Tappy L, Vollenveider P, Jecquier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994; 89: 2634-2640.
85. Gao YY, Lovejoy JC, Sparti A, Bray GA, Keys LL, Partington C. Autonomic activity assessed by heart rate spectral analysis varies with fat distribution in obese women. Obes Res 4: 55-63.
86. Tataranni PA, Young JB, Bogardus C, Ravussin E. A low sympathoadrenal activity is associated with body weight gain and development of central adiposity in Pima Indian men. Obes Res 1997; 5: 341-347.
87. Blaak EE, Van Blaak MA, Kester ADM, Saris WHM. β-adrenergically mediated thermogenic and heart rate responses: effect of obesity and weight loss. Metabolism 1995; 44: 520-524.
88. Astrup A, Buemann B, Gluud C, Bennett P, Tjur T, Christensen N. Prognostic markers for diet-induced weight-loss in obese women. Int J Obes Relat Metab Disord 1995; 19: 275-278.
89. Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med 1991; 324: 739-745.
90. Hofstetter A, Schutz Y, Jecquier E, Wahren J. Increased 24-hour energy expenditure in cigarette smokers. N Engl J Med 1986; 314: 79-82.
91. Grunberg NE. Smoking and body weight: current perspectives and future directions. Ann Behav Med 1989; 11: 154-157.
92. Raben A, Holst J, Christensen NJ, Astrup A. Determinants of postprandial appetite sensations: macronutrient intake and glucose metabolism. Int J Obes Relat Metab Disord 1996; 20: 161-169.
93. Connacher AA, Bennet WM, Jung RT. Clinical studies with the ß-adrenoceptor agonist BRL 26830A. Am J Clin Nutr 1992; 55: 258S-261S.
94. Astrup A, Buemann B, Christensen NJ et al. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women. Metabolism 1992; 41(7): 686-688.
95. Walston J, Silver K, Bogardus C et al. Time of onset of non-insulin dependent diabetes mellitus and genetic variation in the β3-adrenergic-receptor gene. N Engl J Med 1995; 333: 343-347.
96. Clement K, Vaisse C, Manning BJ et al. Genetic variation in the β3-adrenergic-receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333: 352-354.
97. Perusse L, Chagnon YC, Dionne FT, Bouchard C. The human obesity gene map: the 1996 update. Obes Res 1997; 5: 49-61.
98. Kadowaki H, Yasuda K, Iwamoto K et al. A mutation in the β3-adrenergic-receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Bioehem Biophys Res Commun 1995; 215: 555-560.
99. Leibowitz SF. Reciprocal hunger-regulating circuits involving alpha-and beta-adrenergic receptors located, respectively, in the ventromedial and lateral hypothalamus. Proe Natl Aead Sei 1970; 67: 1063-1070.
100. Leibowitz SF, Hoebel BG. Behavioral neuroscience of obesity. In: Bray GA, Bouchard C, James WPT (eds). Handbook of obesity. 1997; pp 313-358. New York: Marcel Dekker.
101. Bray GA, Lin L, Leek V, Smith BK, York DA. Role of the autonomic nervous system in the inhibition of food intake by the β-3 adrenergic drug. Faseb J 1998; 12: A348.